Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2003

01-11-2003 | Concise Article

Comparison of a Commercial Reversed Passive Latex Agglutination Assay to an Enzyme Immunoassay for the Detection of Shiga Toxin-Producing Escherichia coli

Authors: K. C. Carroll, K. Adamson, K. Korgenski, A. Croft, R. Hankemeier, J. Daly, C. H. Park

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2003

Login to get access

Abstract

A multicenter study was performed to compare the performance of a prototypic reversed passive latex agglutination assay (VTEC Screen “Seiken”; Denka-Seiken, Japan) with the Premier EHEC Enzyme Immunoassay (Meridian Diagnostics, USA) for the detection of Shiga toxin in 554 diarrheal stool samples. Standard culture on sorbitol MacConkey agar and the use of latex agglutination reagents were included to identify the Escherichia coli O157, O26 and O111 serotypes. There was 99% agreement between the VTEC screen and enzyme immunoassay (kappa=0.823). Seventeen samples were positive for toxin by one or both assays. One toxin-positive sample using the enzyme immunoassay and four positive samples using the VTEC Screen could not be confirmed. Serotypes identified included: O157:H7 (n=8), O26 (n=2), O111 (n=1) and O45:H2 (n=1). The VTEC screen is easy to perform and comparable to the Meridian EHEC test for detection of Shiga toxin in clinical samples.
Literature
1.
go back to reference Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG and the Hemolytic Uremic Syndrome Study Collaborators (2001) The United States National prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG and the Hemolytic Uremic Syndrome Study Collaborators (2001) The United States National prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed
2.
go back to reference Karch H, Bielaszewska M, Bitzan M, Schmidt H (1999) Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 34:229–243CrossRefPubMed Karch H, Bielaszewska M, Bitzan M, Schmidt H (1999) Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 34:229–243CrossRefPubMed
3.
go back to reference Tarr PI (1995) Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 20:1–10PubMed Tarr PI (1995) Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 20:1–10PubMed
4.
go back to reference Tarr PI, Neill MA (1996) Perspective: the problem of non-O157:H7 Shiga toxin (Verocytotoxin)-producing Escherichia coli. J Infect Dis 174:1136–1139PubMed Tarr PI, Neill MA (1996) Perspective: the problem of non-O157:H7 Shiga toxin (Verocytotoxin)-producing Escherichia coli. J Infect Dis 174:1136–1139PubMed
5.
go back to reference Park CH, Kim HJ, Hixon DL (2002) Importance of testing stool specimens for Shiga toxins. J Clin Microbiol 40:3542–3543CrossRefPubMed Park CH, Kim HJ, Hixon DL (2002) Importance of testing stool specimens for Shiga toxins. J Clin Microbiol 40:3542–3543CrossRefPubMed
6.
go back to reference Chiao E, Mottice S, Dowdle G, Daly J, Barton C, Carroll KC (2000) Demographic data, virulence factors and clinical findings of non-O157 Shiga toxin-producing E. coli (STEC) in Utah. In: Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, no.904 Chiao E, Mottice S, Dowdle G, Daly J, Barton C, Carroll KC (2000) Demographic data, virulence factors and clinical findings of non-O157 Shiga toxin-producing E. coli (STEC) in Utah. In: Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, no.904
7.
go back to reference Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533PubMed Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533PubMed
8.
go back to reference Novicki TJ, Daly JS, Mottice SL, Carroll KC (2000) Comparison of sorbitol MacConkey agar and a two-step method which utilizes a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J Clin Microbiol 38:547–551PubMed Novicki TJ, Daly JS, Mottice SL, Carroll KC (2000) Comparison of sorbitol MacConkey agar and a two-step method which utilizes a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J Clin Microbiol 38:547–551PubMed
9.
go back to reference Kehl KS, Havens P, Behnke CE, Acheson DWK (1997) Evaluation of the Premier EHEC Assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 35:2051–2054 Kehl KS, Havens P, Behnke CE, Acheson DWK (1997) Evaluation of the Premier EHEC Assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 35:2051–2054
10.
go back to reference Kehl SC (2002) Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections. J Clin Microbiol 40:2711–2715CrossRefPubMed Kehl SC (2002) Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections. J Clin Microbiol 40:2711–2715CrossRefPubMed
11.
go back to reference Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479PubMed Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479PubMed
12.
go back to reference Farmer JJ III (2003) Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. American Society for Microbiology, Washington, DC, pp 636–653 Farmer JJ III (2003) Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. American Society for Microbiology, Washington, DC, pp 636–653
13.
go back to reference Bettelheim KA (2001) Development of a rapid method for the detection of verocytotoxin-producing Escherichia coli (VTEC). Lett Applied Microbiol 33:31–35CrossRef Bettelheim KA (2001) Development of a rapid method for the detection of verocytotoxin-producing Escherichia coli (VTEC). Lett Applied Microbiol 33:31–35CrossRef
14.
go back to reference Beutin L, Zimmerman S, Gleier K (2002) Evaluation of the VTEC-Screen “Seiken” test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. Diagn Microbiol Infect Dis 42:1–8CrossRefPubMed Beutin L, Zimmerman S, Gleier K (2002) Evaluation of the VTEC-Screen “Seiken” test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. Diagn Microbiol Infect Dis 42:1–8CrossRefPubMed
15.
go back to reference Chart H, Willshaw GA, Cheasty T (2001) Evaluation of a reversed passive latex agglutination test for the detection of Verocytotoxin (VT) expressed by strains of VT-producing Escherichia coli. Lett Applied Microbiol 32:370–374CrossRef Chart H, Willshaw GA, Cheasty T (2001) Evaluation of a reversed passive latex agglutination test for the detection of Verocytotoxin (VT) expressed by strains of VT-producing Escherichia coli. Lett Applied Microbiol 32:370–374CrossRef
Metadata
Title
Comparison of a Commercial Reversed Passive Latex Agglutination Assay to an Enzyme Immunoassay for the Detection of Shiga Toxin-Producing Escherichia coli
Authors
K. C. Carroll
K. Adamson
K. Korgenski
A. Croft
R. Hankemeier
J. Daly
C. H. Park
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1053-9

Other articles of this Issue 11/2003

European Journal of Clinical Microbiology & Infectious Diseases 11/2003 Go to the issue

Announcements

November 2003

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.